Current role of ischemia-modified albumin in routine clinical practice.
BACKGROUND
Ischemia-modified albumin has been proposed as a useful rule-out marker for the diagnosis of acute coronary syndrome in the emergency department.


OBJECTIVE
To perform a review of ischemia-modified albumin use in the clinical practice.


METHODS
We performed a comprehensive literature search by using electronic bibliographic databases.


CONCLUSIONS
Although the main limitation of ischemia-modified albumin at present is its low specificity, it may be a useful test to rule out acute coronary syndrome from low to moderate pre-test probability conditions with negative cardiac troponins and a negative ECG.
Dominguez-Rodriguez
Alberto
A
Hospital Universitario de Canarias, Department of Cardiology, Tenerife, Spain. adrvdg@hotmail.com
Abreu-Gonzalez
Pedro
P
D015415:Biomarkers / Q000097:blood*; D006801:Humans; D017202:Myocardial Ischemia / Q000175:diagnosis*; D012680:Sensitivity and Specificity; D012709:Serum Albumin / Q000032:analysis*
D015415:Biomarkers; D012709:Serum Albumin